Radioligand therapy trial starts by region

3 regions, 2020 to 2025

79 Global, 2025

Radioligand therapy trial starts by region: 3 regions, 2020 to 2025Radioligand therapy trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 2 to 291. Latest values: Global 79 (2025); United States 39 (2025); China 22 (2025). 0 100 200 300 2020 2021 2022 2023 2024 2025 Global United States China
Radioligand therapy trial starts by region: 3 regions, 2020 to 2025Radioligand therapy trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 2 to 291. Latest values: Global 79 (2025); United States 39 (2025); China 22 (2025). 0 100 200 300 2020 2021 2022 2023 2024 2025 Global United States China
Radioligand therapy trial starts by region: 3 regions, 2020 to 2025Radioligand therapy trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 2 to 291. Latest values: Global 79 (2025); United States 39 (2025); China 22 (2025). 0 100 200 300 2020 2021 2022 2023 2024 2025 Global United States China
View the underlying data
Radioligand therapy trial starts by region: 3 regions, 2020 to 2025
Region Period Type Value
Global 2025 Actual 79
Global 2024 Actual 79
Global 1 Jan 2023 to 27 Sep 2026 Actual 291
Global 2022 Actual 50
Global 2021 Actual 31
Global 2020 Actual 36
United States 2025 Actual 39
United States 2024 Actual 37
United States 1 Jan 2023 to 27 Sep 2026 Actual 127
United States 2022 Actual 27
United States 2021 Actual 15
United States 2020 Actual 17
China 2025 Actual 22
China 2024 Actual 19
China 2023 Actual 18
China 2022 Actual 9
China 2021 Actual 6
China 2020 Actual 2
Chart: StatOrigin · Source: ClinicalTrials.gov · statorigin.org CC BY 4.0